Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory

被引:59
作者
Mattila, MJ
Vanakoski, J
Kalska, H
Seppälä, T
机构
[1] Univ Helsinki, Inst Biomed, Dept Pharmacol & Toxicol, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Dept Appl Psychol, FIN-00014 Helsinki, Finland
[3] Inst Publ Hlth, Helsinki, Finland
关键词
diazepam; ethanol; oxazepam; zolpidem; zopiclone; memory; performance; plasma concentrations;
D O I
10.1016/S0091-3057(97)00506-6
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Zolpidem (Zol), an omega(1)-agonist, acts via GABA(A) receptors but may differ qualitatively from diazepam (Dz) and other benzodiazepines (BZDs). We conducted a placebo-controlled, randomized, double-blind, and crossover study to compare the psychomotor and cognitive effects of 15 mg Zol with those of 15 mg Dz, 30 mg oxazepam (Ox), 7.5 mg zopiclone (Zop), and ethanol (EOH; 0.65 + 0.35 g . kg(-1)) given to 12 subjects at 1-week intervals. Psychomotor tests (symbol digit substitution, simulated driving, nicker fusion, body sway) were done before and 1, 3.5, and 5 h after intake; immediate and delayed memory were measured between 1.5 and 3.5 h. The plasma concentrations of drugs were measured by gas chromatography and by radioreceptor assay (RRA). The mean values of EOH in blood at 1.5, 4, and 5.5 h were 0.82, 0.88, and 0.6 g . l(-1), and the mean values of RRA-assayed plasma Dz were 470, 330, and 210 mu g . l(-1), respectively. The corresponding values of other hypnosedatives, in Dz equivalents (mu g . l(-1)), were 550, 750, and 330 for Ox; 350, 270, and 70 for Zol; and 160, 210, and 70 for Zop. The standard RRA graph for Zol was significantly flatter than those for other hypnotics. Zol impaired coordinative, reactive, and cognitive skills at 1 and 3.5 h more clearly than the other agents did, the most sensitive performance (tracking) still being impaired by Zol at 5 h. Dz and Zop were less active than Zol objectively; subjective sedation after Dz and Zol was stronger than after Zop. Compared to placebo, ail active agents tended to impair learning and memory, their decremental effects, in declining order, being Zol, Dz > EOH, Ox > Zop. During the delay, Dz and Zol caused similar losses of material that had been learned. When separating "true" delayed memory from immediate memory (attention important), Dz and Zol had equieffects on delayed memory and were more detrimental than Zop. When contrasting that against the impaired psychomotor performances,it is possible that 15 mg Zor impairs memory relatively less than 15 mg Dz does. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:917 / 923
页数:7
相关论文
共 31 条
[1]   Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics [J].
Allain, H ;
Patat, A ;
Lieury, A ;
LeCoz, F ;
Janus, C ;
Menard, G ;
Gandon, JM .
EUROPEAN PSYCHIATRY, 1995, 10 :S129-S135
[2]  
BERLIN I, 1993, J CLIN PSYCHOPHARM, V13, P100
[3]   BENZODIAZEPINE RECEPTOR-BINDING OF NONBENZODIAZEPINES INVIVO - ALPIDEM, ZOLPIDEM AND ZOPICLONE [J].
BYRNES, JJ ;
GREENBLATT, DJ ;
MILLER, LG .
BRAIN RESEARCH BULLETIN, 1992, 29 (06) :905-908
[4]  
DECLERC A, 1996, EUR PSYCHIAT S5, V11, pS459
[5]   The mechanism of action of zopiclone [J].
Doble, A ;
Canton, T ;
Malgouris, C ;
Stutzmann, JM ;
Piot, O ;
Bardone, MC ;
Pauchet, C ;
Blanchard, JC .
EUROPEAN PSYCHIATRY, 1995, 10 :S117-S128
[6]   ACUTE ZOLPIDEM POISONING - ANALYSIS OF 344 CASES [J].
GARNIER, R ;
GUERAULT, E ;
MUZARD, D ;
AZOYAN, P ;
CHAUMETRIFFAUD, AE ;
EFTHYMIOU, ML .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1994, 32 (04) :391-404
[7]   CRITICAL FLICKER FUSION FREQUENCY (CFF) - THE EFFECTS OF PSYCHOTROPIC COMPOUNDS [J].
HINDMARCH, I .
PHARMACOPSYCHIATRIA, 1982, 15 :44-48
[8]  
IM HK, 1993, MOL PHARMACOL, V44, P866
[9]   ACTIONS OF ZOPICLONE AND CARBAMAZEPINE, ALONE AND IN COMBINATION, ON HUMAN SKILLED PERFORMANCE IN LABORATORY AND CLINICAL-TESTS [J].
KUITUNEN, T ;
MATTILA, MJ ;
SEPPALA, T ;
ARANKO, K ;
MATTILA, ME .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (03) :453-461
[10]   Zopiclone: Is there any dependence and abuse potential? [J].
Lader, M .
JOURNAL OF NEUROLOGY, 1997, 244 (04) :S18-S22